Over 10 years of studies have shown
ICU glycemic control can improve
outcomes and reduce costs.
Find out more
Real-time continuous glucose monitoring goes
beyond individual isolated measurements
to show you both the direction and rate
of change of your patient's glucose.
Greet Van den Berghe demonstrated that Tight Glycemic
Control in ICU patients yielded significant
improvements in outcomes, including a 34% reduction in
In pilot trials, sensor placement
took less than 10 minutes
of hands-on time.
How it works
In pilot trials patients were
monitored throughout their stay
in the ICU - for up to 120 hours.
See more trial data here
Read what the experts say
An introduction to the clinical data
GlySure Earns ISO 13485 Certification
GlySure has been selected to present as part of Biovision's Top 35 Innovation Companies Investor Conference.
Come and meet us. We will be attending many events in the coming months, find out when and where here.